Lee Ji Eun, Kwon Tae Hui, Gu Su Jin, Lee Duck-Hyung, Kim B Moon, Lee Jae Yeol, Lee Jae Kyun, Seo Seon Hee, Pae Ae Nim, Keum Gyochang, Cho Yong Seo, Min Sun-Joon
Center for Neuro-Medicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul 136-791, South Korea.
Org Biomol Chem. 2014 Aug 14;12(30):5669-81. doi: 10.1039/c4ob00504j. Epub 2014 Jun 25.
This article describes the synthesis and biological evaluation of a chemical library of mibefradil analogues to investigate the effect of structural modification on in vitro stability. The construction of the dihydrobenzopyran structure in mibefradil derivatives 2 was achieved through two efficient approaches based on a diastereoselective intermolecular Reformatsky reaction and an intramolecular carbonyl-ene cyclization. In particular, the second strategy through the intramolecular carbonyl-ene reaction led to the formation of a key intermediate 3 in a short and highly stereoselective way, which has allowed for practical and convenient preparation of analogues 2. Using this protocol, we could obtain 22 new mibefradil analogues 2, which were biologically tested for in vitro efficacies against T-type calcium channels and metabolic stabilities. Among the synthesized compounds, we found that analogue 2aa containing a dihydrobenzopyran ring and a secondary amine linker showed high % remaining activities of the tested CYP enzymes retaining the excellent T-type calcium channel blocking activity. These findings indicated that the structural modification of 1 was effective for improving in vitro stability, i.e., reducing CYP inhibition and metabolic degradation.
本文描述了米贝拉地尔类似物化学文库的合成及生物学评价,以研究结构修饰对体外稳定性的影响。米贝拉地尔衍生物2中二氢苯并吡喃结构的构建通过两种有效方法实现,一种基于非对映选择性分子间瑞福马斯基反应,另一种基于分子内羰基-烯环化反应。特别地,通过分子内羰基-烯反应的第二种策略以简短且高度立体选择性的方式生成了关键中间体3,这使得类似物2的制备实用且方便。使用该方案,我们能够获得22种新的米贝拉地尔类似物2,并对其针对T型钙通道的体外效力和代谢稳定性进行了生物学测试。在合成的化合物中,我们发现含有二氢苯并吡喃环和仲胺连接基的类似物2aa在保留优异的T型钙通道阻断活性的同时,所测试的CYP酶的剩余活性百分比很高。这些发现表明,对1进行结构修饰可有效提高体外稳定性,即减少CYP抑制和代谢降解。